NEW YORK, Nov. 16, 2016 /PRNewswire/ -- The global Immunodiagnostics market is projected to grow with a CAGR of 6.6% from 2016 to 2021. Immunodiagnostics is a class of in vitro diagnostics that utilizes antigen-antibody reaction as its primary means of detecting infectious diseases, tumors, drug abuse, diabetes, proteins, therapeutic drugs, and allergens. Immunodiagnostics tests are analytical methods that require different immunodiagnostics instruments and antibodies as reagents against the desired antigens to be detected. The results of the tests are used to help in diagnosis, and they have widespread clinical applications. Immunodiagnostics tests are also helpful in the field of forensic science, environmental science, and food analysis. The global immunodiagnostics market is divided into two segments: immunodiagnostic instruments and reagents. Segments Covered:The report segments the global Immunodiagnostics market by product type, application, and region. The product types include Immunodiagnostic Reagents and Immunodiagnostic Instruments. Similarly, the applications covered in the report include Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Diseases Testing, and GI Stool Testing. Geographic Coverage and Analysis: The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. Among the various regions covered, North America dominated the global Immunodiagnostics market. Companies profiled:The companies covered in the report include Abbott Diagnostics, Beckman Coulter Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Affimetrix, Alere, Allele Biotechnology, Axis-Shield, bioM`rieux, Diametra, DiaSorin, Enzo Life Sciences, ImmunoDX, Immunonodiagnostics System, InDevR, Merck Millipore, and Meridian Bioscience.